Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Toyooka

Showing results (481-490 of 537) with videos related to

Pageof 54
Sort By:
Plos One|February 4, 2017
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancerTatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki, et al.
Cancer Research|December 4, 2002
Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinomaFumiaki Sato, David Shibata, Noam Harpaz, et al.
Breast Cancer (Tokyo, Japan)|November 13, 2020
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese womenKengo Kawada, Naruto Taira, Taeko Mizoo, et al.
Pathology International|September 21, 2020
Multiplex gene-panel testing for lung cancer patientsYasushi Yatabe, Kuniko Sunami, Koichi Goto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2022
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in AsiaTetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2020
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung CancerHirotsugu Kenmotsu, Nobuyuki Yamamoto, Takeharu Yamanaka, et al.
General Thoracic and Cardiovascular Surgery|May 17, 2021
Current status of inhaled nitric oxide therapy for lung transplantation in Japan: a nationwide surveyNobuyuki Yoshiyasu, Masaaki Sato, Daisuke Nakajima, et al.
Chest|May 11, 2019
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka, et al.
Frontiers in Oncology|April 24, 2023
Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2Ni Luh Gede Yoni Komalasari, Nahoko Tomonobu, Rie Kinoshita, et al.
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
Pageof 54

Showing results (481-490 of 537) with videos related to

Sort By:
Pageof 54
Plos One|February 4, 2017
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancerTatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki, et al.
Cancer Research|December 4, 2002
Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinomaFumiaki Sato, David Shibata, Noam Harpaz, et al.
Breast Cancer (Tokyo, Japan)|November 13, 2020
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese womenKengo Kawada, Naruto Taira, Taeko Mizoo, et al.
Pathology International|September 21, 2020
Multiplex gene-panel testing for lung cancer patientsYasushi Yatabe, Kuniko Sunami, Koichi Goto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2022
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in AsiaTetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2020
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung CancerHirotsugu Kenmotsu, Nobuyuki Yamamoto, Takeharu Yamanaka, et al.
General Thoracic and Cardiovascular Surgery|May 17, 2021
Current status of inhaled nitric oxide therapy for lung transplantation in Japan: a nationwide surveyNobuyuki Yoshiyasu, Masaaki Sato, Daisuke Nakajima, et al.
Chest|May 11, 2019
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka, et al.
Frontiers in Oncology|April 24, 2023
Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2Ni Luh Gede Yoni Komalasari, Nahoko Tomonobu, Rie Kinoshita, et al.
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
Pageof 54